Loading...
Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer
Proton beam therapy (PBT) is becoming an increasingly common option for patients undergoing radiation therapy (RT). With the concurrent emergence of immunotherapy as an effective systemic treatment for historically treatment-resistant disease such as advanced non-small cell lung cancer (NSCLC), the...
Saved in:
| Published in: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5960663/ https://ncbi.nlm.nih.gov/pubmed/29876317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2018.03.28 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|